Collegium Pharmaceutical Other Long Term Liabilities (Quarterly) Analysis

Collegium Pharmaceutical, Inc. (COLL)

47.34 +0.06 (+0.13%) USD | NASDAQ | Jan 14, 12:34

View Other Long Term Liabilities (Quarterly) for COLL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Catalyst Pharmaceuticals, Inc.	Upgrade
Intuitive Surgical, Inc.	Upgrade
Alnylam Pharmaceuticals, Inc.	Upgrade
Corcept Therapeutics, Inc.	--
Altimmune, Inc.	Upgrade